1389307-18-9

Basic information

• Product Name: acacetin-7-O-β-D-hepta-O-acetyllactoside
• Synonyms: acacetin-7-O-β-D-hepta-O-acetyllactoside
• CAS NO: 1389307-18-9
• Molecular Weight: 902.814
• Mol File: 1389307-18-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: acacetin-7-O-β-D-hepta-O-acetyllactoside(CAS DataBase Reference)
• NIST Chemistry Reference: acacetin-7-O-β-D-hepta-O-acetyllactoside(1389307-18-9)
• EPA Substance Registry System: acacetin-7-O-β-D-hepta-O-acetyllactoside(1389307-18-9)

Safety Data

• Hazardous Substances Data: 1389307-18-9(Hazardous Substances Data)

Upstream product

• 480-44-4 5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one 
• 10236-47-2 naringin 

Downstream Products

• 1389307-24-7 acacetin-7-O-β-D-lactoside 

Relevant articles and documents

Semisynthesis of apigenin and acacetin-7-O-β-d-glycosides from naringin and their cytotoxic activities

Apigenin-7-O-β-d-glycosides 1-8 and acacetin-7-O-β-d-glycosides 9-16 were semisynthesized from 4′-O-benzyl apigenin 17 and acacetin 18 by glycosidation and deprotection with the corresponding α-acetylglycosyl bromide, respectively. Compounds 17 and 18 were prepared by iodination followed by base-induced elimination, 4′-O-benzylation, or 4′-O-methylation and acid hydrolysis using naringin as starting material which is readily available and cheap. Their cytotoxic potential against five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, and SW480) was evaluated by standard MTT method. The results show that compounds 2, 9, and 19 exhibit moderate cytotoxicity against HL-60, SMMC-7721, A-549, MCF-7, and SW480, while compound 3 exhibits potent cytotoxicity against MCF-7 selectively. Among the synthesized target compounds, 3, 4, 7, 11, 12, 15, and 16 were new compounds, the natural product 8 was the first synthesized and the synthesis of natural products 5, 6, 13, and 14 was efficiently improved by the new synthetic routes.